Oncolytics Biotech

ONCY

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodif …

Insider trades and stock quote 2024-2026

All insider trades at Oncolytics Biotech

Subscribe RSS
Date Type Insider Position Ø-Price Volume
3/12/2026 Buy Kelly, Jared Chief Executive Officer $1.0 $4,848
3/11/2026 Buy Parsons, James T. Director $1.0 $10,300
2/12/2026 Buy Andrews, Patricia S. Director $0.9 $30,292
2/12/2026 Buy Brown, Deborah Margaret Director $0.8 $21,240
2/12/2026 Buy Hagerman, Allison VP, Product Development $0.8 $8,298
2/12/2026 Buy Heineman, Thomas Charles Chief Medical Officer $0.8 $10,033
2/12/2026 Buy Kelly, Jared Chief Executive Officer $0.8 $24,839
2/12/2026 Buy Look, Kirk Chief Financial Officer $0.8 $10,104
2/12/2026 Buy Pisano, Wayne Director $0.8 $25,338
2/12/2026 Buy Seizinger, Bernd R. Director $0.8 $33,864
2/11/2026 Buy Aromando, Andrew Chief Business Officer $0.9 $25,418
2/11/2026 Buy Kelly, Jared Chief Executive Officer $0.8 $4,682
2/11/2026 Buy Seizinger, Bernd R. Director $0.8 $49,590
1/16/2026 Buy Seizinger, Bernd R. Director $1.0 $103,770
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)